Page 6 - Read Online

9 [ F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular
18
carcinoma model treated with sorafenib
Fernando Gomes de Barros Costa, José Tadeu Stefano, Daniele de Paula Faria, Caio de Souza Levy,
Maria Cristina Chammas, Camila de Godoi Carneiro, Isabel Veloso Alves Pereira, Bruno Cogliati,
Flair José Carrilho, Claudia P. Oliveira
Hepatoma Res 2018;4:35 http://dx.doi.org/10.20517/2394-5079.2018.06

10 Aberrant pre-mRNA splicing regulation in the development of hepatocellular carcinoma
Supriya Sen
Hepatoma Res 2018;4:37 http://dx.doi.org/10.20517/2394-5079.2018.39

11 Oxidative stress and hepatocarcinogenesis
Ying Fu, Fung-Lung Chung
Hepatoma Res 2018;4:39 http://dx.doi.org/10.20517/2394-5079.2018.29

12 Molecular mechanism of hepatocellular carcinoma
Seung Kew Yoon
Hepatoma Res 2018;4:42 http://dx.doi.org/10.20517/2394-5079.2018.23

13 The fibroblast growth factor receptor pathway in hepatocellular carcinoma
Joycelyn Jie Xin Lee, Su Pin Choo
Hepatoma Res 2018;4:52 http://dx.doi.org/10.20517/2394-5079.2018.42

14 Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and
alcoholic and non-alcoholic fatty liver disease
Riccardo Nevola, Luca Rinaldi, Mauro Giordano, Aldo Marrone, Luigi Elio Adinolfi
Hepatoma Res 2018;4:55 http://dx.doi.org/10.20517/2394-5079.2018.38

Original Article

15 Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a
radioisotopic, physiological and biochemical analysis
Nisha Bhatia, Baljinder Singh, Ashwani Koul
Hepatoma Res 2018;4:9 http://dx.doi.org/10.20517/2394-5079.2018.04

16 Beta2-glycoprotein I cooperate with hepatitis B surface antigen promotes hepatocellular
carcinogenesis via the nuclear factor kappa B signal pathway were enhanced by the lipopolysaccharide
Xue-Li Ding, Xue Jing, Nai-Jun Han, Zi-Bin Tian, Pu-Jun Gao, Lin Yang, Ya-Nan Yu
Hepatoma Res 2018;4:12 http://dx.doi.org/10.20517/2394-5079.2018.07